2024 AUA Recaps : Episode 2

News

Video

AUA 2024: Dr. Zorn recaps key BPH research

In this video, Kevin C. Zorn, MD, FRCSC, FACS, discusses key BPH data from the 2024 American Urological Association Annual Meeting.

In this video, Kevin C. Zorn, MD, FRCSC, FACS, recaps data in benign prostatic hyperplasia (BPH) that was presented at the 2024 American Urological Association Annual Meeting in San Antonio, Texas. Zorn is the founder and director of BPH Canada in Montreal.

The following research is discussed:

1. P2-13: Preliminary RCT Analysis of Minimally Invasive Surgery vs. Medication in the Initial Treatment of BPH-Associated LUTS

2. MP27-04: Multi-center report on acute clinical outcomes with Rivermark FloStent™

3. MP20-02: Aquablation at 4-years: the largest, real world, single-center study and longest follow-up data for this innovative BPH treatment

4. MP46-03: Preservation of Sexual Function with Optilume: A Novel Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

5. MP20-05: Day Case Aquablation: First Published Experience Report in Ambulatory Surgical Center (ASC)

Related Videos
Raevti Bole, MD, answers a question during a video interview
Justin Dubin, MD, answers a question during a video interview
Landon Trost, MD, answers a question during a video interview
Jake Miller, MD, answers a question during a video interview
Michael Jenson, PA-C, answers a question during a Zoom video interview
young asian doctor talking to senior couple patients in hospital hallway | Image Credit: © imtmphoto - stock.adobe.com
Male doctor examining patient | Image Credit: © Rawpixel.com - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.